1. Home
  2. Labeler Index
  3. Macleods Pharmaceuticals Limited
  4. 33342-288
  5. Product Images: Sevelamer Carbonate

Product Images Sevelamer Carbonate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Sevelamer Carbonate NDC 33342-288 by Macleods Pharmaceuticals Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

666 - sevelamer carbonate suspension 2 4g 90s cont

666 - sevelamer carbonate suspension 2 4g 90s cont

This is a description for a pharmaceutical product named Sevelamer Carbonate for Oral Suspension in citrus flavor. Each box contains 90 packets of the medication. The manufacturer is Macleods Pharmaceuticals Ltd. and the product is for Macleods Pharma USA, Inc. It is manufactured in Baddi, Himachal Pradesh, INDIA. The usual dosage is 2.4 of sevelamer carbonate. The medication packet includes inactive ingredients such as mannitol, ferric oxide yellow, povidone, xanthan gum, sodium chloride, sucralose, orange flavor, vanilla flavor, and lemon-lime flavor. The directions advise emptying a packet into 2 ounces of water, stir well and drink within 30 minutes. It is essential to store the medication at 20° to 25°C (68° to 77°F) and protect it from moisture.*

111 - sevelamer carbonate suspension 8g 90s cont

111 - sevelamer carbonate suspension 8g 90s cont

This text contains information about a medication called Sevelamer Carbonate for Oral Suspension in Citrus Flavor. Each packet contains 0.8g of sevelamer carbonate, along with various inactive ingredients. The medication is produced by Macleods Pharma and is stored at a temperature between 20°C to 25°C. Directions for use include emptying a packet into a cup with water and consuming it within 30 minutes. It is essential to keep the medication away from moisture and out of reach of children.*

str - sevelamer figure 1

str - sevelamer figure 1

fig-2 - sevelamer figure 2

fig-2 - sevelamer figure 2

fig-1 - sevelamer figure 3

fig-1 - sevelamer figure 3

This text provides information about a reduction in serum phosphorus levels. The data includes values related to active control, reduction from baseline, and reduction in serum phosphorus in mg/dL. It seems to be a measurement or evaluation related to a medical or scientific study.*

fig-4 - sevelamer figure 4

fig-4 - sevelamer figure 4

Not available.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.